Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450771 · ClinicalTrials.gov registry record · NA
Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID
A NA study of Avoidant Restrictive Food Intake Disorder, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT04450771: Completed NA study of Avoidant Restrictive Food Intake Disorder, sponsored by Stanford University.
NCT04450771 is a NA study of Avoidant Restrictive Food Intake Disorder that has completed, run by Stanford University. The registered enrollment target is 98 participants, below the 4,033-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04450771, a NA study of Avoidant Restrictive Food Intake Disorder, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is examining the efficacy and mechanism of family therapy compared to usual care for children between the ages of 6 and 12 who are diagnosed with Avoidant/Restrictive Food Intake Disorder. Preliminary data suggest that family therapy is superior to usual care and that improvement in parental self-efficacy related to feeding their children is the mechanism of treatment. In addition, this study will attempt to identify specific patient groups who respond to family therapy.
Primary Outcome
Expected Body Weights (EBW) percentages used will be calculated using Center for Disease Control metrics in children and adolescents.
Conditions Studied
Interventions
- BEHAVIORAL Family-based Treatment for ARFID
- BEHAVIORAL Manualized Non-Specific Usual Care for ARFID
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2026-01-16 |
| Phase | NA |
What the finished NCT04450771 record still lists
NCT04450771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 4,033-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Avoidant Restrictive Food Intake Disorder appearing as the primary indexed condition, and to 2 interventions - of which Family-based Treatment for ARFID is the first listed.
NCT04450771 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04450771 about?
NCT04450771 is a clinical study titled "Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID". This study is examining the efficacy and mechanism of family therapy compared to usual care for children between the ages of 6 and 12 who are diagnosed with Avoidant/Restrictive Food Intake Disorder. Preliminary data suggest that family therapy is superior to usual care and that improvement in paren...
What is the current status of trial NCT04450771?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2020-12-01. Estimated completion is 2026-01-16.
What conditions does trial NCT04450771 study?
This clinical trial studies the following conditions: Avoidant Restrictive Food Intake Disorder.
What interventions are being tested in trial NCT04450771?
The interventions under investigation include: Family-based Treatment for ARFID (BEHAVIORAL), Manualized Non-Specific Usual Care for ARFID (BEHAVIORAL).
Who is sponsoring clinical trial NCT04450771?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04450771 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avoidant Restrictive Food Intake Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Evaluating Hunger Manipulation During Feeding Intervention
COMPLETED · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
The Use of Cyproheptadine in Pediatric Feeding Disorders
ACTIVE NOT RECRUITING · Phase 4
-
CGM in Patients With ED's
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI